Thyroid nodules are uncommon in children and adolescents – and that is exactly why they matter. Otolaryngologist Dr Francis Hall sets out what raises the level of concern, and when to refer.
The prevalence of thyroid nodules increases with age, and nodules are much less common in younger patients. Using ultrasound, some studies suggest thyroid nodules occur in 1% of children less than 10 years old, 13% of adolescents (10–19 years old) and 65% of adults. Thyroid nodules are more common in women than men.
The risk of malignancy in a thyroid nodule increases with decreasing age. About 25% of thyroid nodules in children are malignant compared with 5% of thyroid nodules in adults. Therefore, the younger the patient, the more likely a thyroid nodule is malignant.
Radiation exposure
Radiation exposure to the thyroid is a major risk factor for developing papillary thyroid carcinoma, and children less than five years old are very sensitive to the development of radiation-induced thyroid cancer. Radiation exposure also increases the prevalence of benign thyroid nodules. Approximately 5% of children with differentiated thyroid carcinoma have a history of radiation exposure, and that exposure is usually due to medical treatment.
Up to 10% of paediatric cancer survivors develop thyroid cancer, with a median latency period of 10 years and a range of 5–20+ years. Even low-dose radiation exposure (0.1 GY) is associated with an increased risk of developing papillary thyroid carcinoma. Because of the increased risk after radiotherapy in young children, some authorities recommend ultrasound surveillance.
Family history
Familial non-medullary thyroid cancer accounts for about 5% of all differentiated thyroid cancer (papillary and follicular thyroid cancer) and is divided into syndromic (95%) and non-syndromic (5%) forms. Therefore, a family history of thyroid cancer, either medullary or papillary, raises the level of concern that a thyroid nodule is malignant.
Syndromes associated with an increased incidence of thyroid cancer include familial adenomatous polyposis (APC gene), PTEN hamartoma syndrome (PTEN gene) and DICER1 syndrome (DICER1 gene).
Red flags
In both children and adults, rapid growth of a thyroid nodule, cervical lymphadenopathy, a hoarse voice, and difficulty breathing or swallowing are all red flags, and prompt referral to a thyroid specialist is recommended.
Investigating a nodule in a young patient
It is recommended that thyroid nodules in the young are investigated in a similar fashion to adults, with thyroid function tests, ultrasound and fine-needle aspiration (FNA) depending on the ultrasound results. An important difference is that the threshold to perform FNA is lower in the young than in adults.
This is because thyroid nodules in children are more likely to be malignant than in adults, and thyroid cancer in children is more likely to metastasise than in adults, so the consequences of missing a thyroid cancer are higher. For both reasons, FNA is performed in a higher proportion of thyroid nodules in children than in adults.
Finally, surveillance of thyroid nodules with indeterminate cytology on FNA (Bethesda 3 and 4) is generally not recommended in the paediatric population.
What the cancers look like
The most common type of thyroid cancer in children is papillary thyroid carcinoma (90%), followed by follicular thyroid carcinoma (10%). When histology and tumour size are controlled for, lymph node involvement, extrathyroidal extension and pulmonary metastases are more common in children than in adults. Fortunately, despite the higher proportion of extensive disease, children are less likely to die from thyroid cancer than adults.
Thyroid cancer in children is much less likely to be BRAF positive than in adults, and more likely to be RET/PTC positive. The American Thyroid Association guidelines recommend that treatment of thyroid cancer in children and adults is based on risk stratification, which has resulted in fewer patients being treated with radioactive iodine.
Summary
Thyroid nodules are much less common in children than in adults but are more likely to be malignant, so early referral for specialist care is recommended.
Up to 10% of patients who have radiotherapy before the age of 10 subsequently develop thyroid cancer.
REFERENCES
1. Ringel MD, et al. 2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer. Thyroid 2025; 35(8): 841–985.
2. Francis GL, et al. Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid 2015; 25(7): 716-759.
3. Lebbink CA, et al. 2022 European Thyroid Association guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma. Eur Thyroid J. 2022; 11(6).
4. Lai S-TT, et al. Approach to the pediatric patient with thyroid nodules. J Clin Endocrinol Metab. 2025 Jul 15; 110(8): 2339–2352.